249294-69-7Relevant academic research and scientific papers
Selective A3 adenosine receptor antagonists: Water-soluble 3,5-diacyl- 1,2,4-trialkylpyridinium salts and their oxidative generation from dihydropyridine precursors
Xie, Rongyuan,Li, An-Hu,Ji, Xiao-Duo,Melman, Neli,Olah, Mark E.,Stiles, Gary L.,Jacobson, Kenneth A.
, p. 4232 - 4238 (1999)
A3 adenosine receptor antagonists are sought for their potential antiinflammatory, antiasthmatic, and antiischemic properties. We have found that 3,5-diacyl-1,2,4-trialkyl-6-phenylpyridinium derivatives constitute a novel class of selective As
Methods for reducing intraocular pressure using A3 adenosine receptor antagonists
-
, (2008/06/13)
This invention relates to a method of decreasing intraocular pressure by administrating an A3 subtype adenosine receptor antagonist, a calmodulin antagonist or an antiestrogen such as tamoxifen.
